Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Danish Trial of Beta Blocker Treatment After Myocardial Infarction Without Reduced Ejection Fraction (DANBLOCK)

NCT03778554 is registered in ClinicalTrials.gov with Bispebjerg Hospital as lead sponsor.

NCT NCT03778554
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03778554 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Danish Trial of Beta Blocker Treatment After Myocardial Infarction Without Reduced Ejection Fraction (DANBLOCK)
Lead sponsor
Bispebjerg Hospital
Phase
Phase 4
Overall status
Active, not recruiting
Start date
December 17, 2018
Completion date
December 10, 2035
Enrollment
2,760 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myocardial infarction, non-st elevation myocardial infarction (nstemi), st elevation myocardial infarction